ADIM
RVNC

Alpha DNA Investment Management’s Revance Therapeutics, Inc. RVNC Stock Holding History

Alpha DNA Investment Management’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-33,552
Closed -$1.08M – 219
2023
Q1 		$1.08M Buy
+33,552
New +$1.08M 0.32% 81